Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 105

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 105
---
 States.

Your right to participate in any future rights offerings may be limited, which may cause dilution to your holdings.

Under English law, shareholders
usually have preemptive rights to subscribe on a pro rata basis in the issuance of new shares for cash. The exercise of preemptive rights
by certain shareholders not resident in the United Kingdom may be restricted by applicable law or practice in the United Kingdom and overseas
jurisdictions. We may from time to time distribute rights to our shareholders, including rights to acquire our securities. However, we
cannot make rights available to shareholders in the United States unless we register the rights and the securities to which the rights
relate under the Securities Act or an exemption from the registration requirements is available. Also, under the deposit agreement, the
depositary bank will not make rights available to Depositary Share holders unless either both the rights and any related securities are
registered under the Securities Act, or the distribution of them to Depositary Share holders is exempted from registration under the Securities
Act. We are under no obligation to file a registration statement with respect to any such rights or securities or to endeavor to cause
such a registration statement to be declared effective. Moreover, we may not be able to establish an exemption from registration under
the Securities Act. If the Depositary does not distribute the rights, it may, under the deposit agreement, either sell them, if possible,
or allow them to lapse. Accordingly, Depositary Share holders may be unable to participate in our rights offerings and may experience
dilution in their holdings. We are also permitted under English law to disapply preemptive rights (subject to the approval of our shareholders
by special resolution or the inclusion in our articles of association of a power to disapply such rights) and thereby exclude certain
shareholders, such as overseas shareholders, from participating in a rights offering (usually to avoid a breach of local securities laws).

| 51 |

It may be difficult for you to bring any action or enforce any judgment obtained in the United States against us or members of our Board of Directors, which may limit the remedies otherwise available to you.

We are incorporated as a public
limited company in England and Wales and all of our assets are located outside the United States. In addition, all of the members of our
Board of Directors are nationals and residents of countries, including the United Kingdom, outside of the United States. Most or all of
the assets of these individuals are located outside the United States. As a result, it may